Cover Image
Market Research Report

Medical Device Contract Manufacturing Market, 2019-2030

Published by ROOTS ANALYSIS Product code 853654
Published Content info 323 Pages
Delivery time: 1-2 business days
Price
Back to Top
Medical Device Contract Manufacturing Market, 2019-2030
Published: May 31, 2019 Content info: 323 Pages
Description

Example Insights:

In the last six years, over 9,600trials evaluating various medical devices have been registered by different types of sponsors covering a wide range of therapeutic areas.

Overview:

Recent advances in data science technology solutions, such as Internet of Things, machine learning, artificial intelligence and real world evidence-based solutions, have enabled medical device developers to digitize and automate a number of product development and manufacturing processes. In 2020, the global medical devices market is estimated to reach a net worth of approximately USD 430 billion. However, most developers lack adequate resources and the necessary expertise to manufacture medical devices and related components. Moreover, given the rapid rate of evolution, the costs associated with acquiring the necessary infrastructure and capabilities in this field are high; therefore, it is difficult for companies with limited finances to acquire such resources and carry out such operations by themselves. In addition, the evolving regulatory guidelines and complicated pathways to establishing reimbursement strategies render medical devices subject to rigorous quality assessments, especially for medium and high risk devices. The aforementioned constraints have led many of the smaller players and certain established players to outsource a significant part of their manufacturing operations to capable contract manufacturing organizations (CMOs). CMOs are known to offer significant cost-benefits, access to sophisticated / up-to-date infrastructure, large production capacities and reduction in time-to-market.

Given the demand for medical devices, the opportunity for CMOs with expertise in medical devices is steadily rising. In fact, in 2018 alone, the USFDA approved over 100 medical devices. It is worth highlighting that, since 2000, more than 65 CMOs have been established. The demand for one-stop-shops and versatile supply chain management solutions have fuelled consolidation activity in this domain. Contemporary contract service providers have been focusing on bolstering in-house capabilities to offer a wider range of services to their clients, covering product design to distribution and marketing, along with regulatory assistance. The medical device sector is among the most highly regulated industries, and we expect the demand for core competencies, such as design and engineering, prototype development and high volume manufacturing, to continue to drive sponsor companies to outsource various parts of their product development and manufacturing operations to capable contract service providers. Amidst tough competition, the availability of advanced tools and technologies is an important differentiating factor; CMOs that invest in such upgrades are likely to gain a competitive edge.

Scope of the Report:

The “Medical Device CMOs Market, 2019-2030” report features a comprehensive study on the current landscape of contract manufacturing service providers focused on medical devices (specifically for drug-delivery devices, diagnostic devices and therapeutic devices). The scope of the report primarily includes those manufacturers that offer finished product services for medical devices (excluding medical equipment, such as X-ray machines, ultrasound machines, operating tables and other similar products). The study features an in-depth analysis, highlighting the capabilities of the various stakeholders engaged in this domain, across different regions of the globe. Amongst other elements, the report includes:

  • A detailed review of the overall landscape of the medical device contract manufacturing market, featuring a list of CMOs engaged in this domain, and detailed analysis based on a number of relevant parameters, such as year of establishment, size of employee base, manufacturing facilities, geographical location, type of device manufactured (drug-delivery devices, diagnostic devices, therapeutic devices and others), scale of operation (precommercial and commercial) and types of services offered ([A] production services (such as design services, prototyping, component manufacturing, packaging, and sterilization), [B] post-production services (such as supply chain management services, labeling services, logistics, and shipping services) and [C] other services (such as regulatory services, project management services and documentation services).
  • An elaborate discussion on the various guidelines established by major regulatory bodies for medical device approval, across different countries. The report also features an insightful multi-dimensional bubble analysis, featuring a comparison of the contemporary regulatory scenario in key geographies across the globe.
  • A benchmark analysis, highlighting the key focus areas of small-sized, mid-sized and large companies, comparing their existing capabilities within and beyond their respective peer groups, providing a means for stakeholders to identify ways to gain a competitive edge in the industry.
  • An analysis of the medical device supply-chain, highlighting the role of CMOs engaged in this domain and analysis based on services offered, such as supply chain management services, logistics services, shipping services and warehousing services, to medical device companies.
  • Elaborate profiles of popular players that specialize in providing services for both precommercial and commercial scale manufacturing of medical devices. Each profile features an overview of the company, its service portfolio, details on manufacturing facilities, as well as an informed future outlook.
  • A geographical clinical trial analysis of ongoing and planned studies related to medical devices, featuring details related to medical devices being investigated across various geographies, based on the number of registered trials, current status of trials, phase of development, type of sponsor, therapeutic area(s) and target disease indication(s), and number of patients enrolled.
  • A detailed analysis of the mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2014-2019. The analysis provides information on the key value drivers for these mergers and acquisitions and the corresponding acquisition deal multiples. In addition, the analysis features an ownership change matrix, providing a summary of the involvement of private and public sector entities in this domain.
  • An elaborate discussion on the future opportunities / trends related to the medical device contract manufacturing market that are likely to influence the growth within this domain over the coming years.
  • A discussion on affiliated trends, key drivers and challenges, under a comprehensive SWOT framework, featuring a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on the overall medical device CMO industry.

One of the key objectives of this report was to evaluate the current opportunity and the future market potential of the medical device CMOs market over the coming decade. We have provided an informed estimate of the likely evolution of the market in the short to mid-term and long term, for the period 2019-2030. In addition, we have provided the likely distribution of the opportunity across different [A] type of devices (drug-delivery, therapeutic and diagnostic devices), [B] device class (class I, class II and class III), [C] therapeutic areas (cardiovascular disorders, CNS disorders, metabolic disorders, oncological disorders, orthopedic disorders, ophthalmic disorders, pain disorders, respiratory disorders, and others), and [D] geographical regions (North America, Europe, Asia-Pacific and rest of the world) and [E] leading players. To account for the uncertainties associated with the growth of the medical device CMO market and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market's evolution.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Chapter Outlines:

Chapter 2 is an executive summary of the key insights captured in our research. It offers a high-level view on the current state of the medical device contract manufacturing market and its likely evolution in the short-mid and long terms.

Chapter 3 provides a brief introduction to medical devices, highlighting key historical milestones, their classification, and associated manufacturing requirements. It emphasizes on the contract services market for such medical products, featuring an overview of the various challenges faced by medical device manufacturers, and highlighting the role of CMOs and diverse range of benefits offered by such service provider entities. It also includes a discussion on the services offered by CMOs, along with a list of advantages and risks associated with outsourcing. Further, it describes the various factors that need to be taken into consideration by sponsor companies, while selecting a suitable CMO partner.

Chapter 4 features a detailed discussion on the various guidelines established by regulatory bodies for medical device approval, across different geographical regions, namely North America (the US and Canada), Europe (specifically the UK scenario), and Asia-Pacific (Japan, China and Australia). In addition, the chapter features an insightful, multi-dimensional bubble analysis that compares the current regulatory scenario within the overall medical device industry.

Chapter 5 provides a comprehensive overview of the overall landscape of drug-delivery device CMOs. It includes information related to over 70 companies that actively offer manufacturing services for drug-delivery devices. In addition, it features an in-depth analysis of the market, based on parameters such as year of establishment, size of employee base, location of manufacturing facility, scale of operation (precommercial and commercial) and types of services offered.

Chapter 6 provides a comprehensive overview of the overall landscape of diagnostic device CMOs. It includes information related to over 80 companies that actively offer manufacturing services for diagnostic devices. In addition, it features an in-depth analysis of the market, based on parameters such as year of establishment, size of employee base, location of manufacturing facility, scale of operation (precommercial and commercial) and types of services offered.

Chapter 7 provides a comprehensive overview of the global landscape of therapeutic device CMOs. It includes information related to over 170 companies that actively offer manufacturing services for therapeutic devices. In addition, it features an in-depth analysis of the market, based on parameters such as year of establishment, size of employee base, location of manufacturing facility, scale of operation (precommercial and commercial) and types of services offered.

Chapter 8 presents a benchmark analysis of the various players engaged in this domain. It highlights the capabilities of small-sized, mid-sized and large companies in terms of their expertise in medical device related services. Further, the analysis allows companies to compare their existing capabilities within and beyond their respective peer groups, providing a means for stakeholders to identify ways to gain a competitive edge in the industry.

Chapter 9 features an analysis of the medical device value-chain, highlighting the role of CMOs engaged in this domain and analysis based on services such as, such as supply chain management services, logistics services, warehouse services and shipping services.

Chapter 10 features detailed profiles of popular players that specialize in providing services for both precommercial and commercial stage medical device manufacturing. Each profile features an overview of the company, its service portfolio, details on manufacturing facilities, and an informed future outlook.

Chapter 11 presents a geographical clinical trial analysis of ongoing and planned studies related to medical devices. For the purpose of this analysis, we considered those clinical studies that have been initiated since 2013 and analysed them on the basis of various parameters, such as year of registration, regional distribution, current status of trials, phase of development, funder type, therapeutic area(s) and target disease indication(s), and number of patients enrolled across different geographies.

Chapter 12 features a detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2014-2019, based on parameters such as key value drivers, year of acquisition, type of acquisition, geographical location of the acquirer and the acquired company, and financial details of the deal (if available). The analysis also features an ownership change matrix, providing insights on the involvement of private and public sector entities in this domain. In addition, the chapter evaluates the deal multiples of acquisitions specifically focused on medical devices, analyzing them based on a number of parameters, namely annual revenues, number of employees and the experience of the acquired company. Moreover, it presents a schematic world map representation of the geographical distribution of this activity, highlighting inter- and intracontinental deals.

Chapter 13 features a case study highlighting the manufacturing overview of key market sectors, such as automobiles, telecommunication, banking, defense and aerospace that have experienced tremendous growth within emerging markets. It highlights the ongoing evolution in medical device manufacturing industry within developed and emerging countries, featuring a qualitative comparative analysis. Further, the chapter includes discussions regarding the business models, associated challenges and strategies to mitigate these constraints for multinational, medical device-focused companies within emerging countries.

Chapter 14 presents a likely evolution of the market in the short to mid-term and long term (2018-2030). In addition, we have provided the likely distribution of the opportunity across different A] type of device (drug-delivery, therapeutic and diagnostic devices), [B] device class (class I, class II and class III), therapeutic areas (cardiovascular disorders, CNS disorders, metabolic disorders, oncological disorders, orthopedic disorders, ophthalmic disorders, pain disorders, respiratory disorders, and others), and [D] geographical regions (North America, Europe, Asia-Pacific and rest of the world) and [E] leading players.

Chapter 15 provides a discussion on affiliated trends, key drivers and challenges, under a comprehensive SWOT framework, featuring a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on the overall medical devices CMO industry.

Chapter 16 is a summary of the entire report. It provides the key takeaways and presents our independent opinion of the medical device CMOs market, based on the research and analysis described in the previous chapters. It also provides a recap of some of the upcoming future trends, which, we believe, are likely to influence the growth of medical device CMOs.

Chapter 17 is a collection of survey transcripts of the discussions held with key stakeholders in this market.

Chapter 18 is an appendix that contains tabulated data and numbers for all the figures provided in the report.

Chapter 19 is an appendix that contains the list of companies and organizations mentioned in this report.

Table of Contents

Table of Contents

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
  • 1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Overview of Medical Devices
    • 3.2.1. History of Medical Devices
    • 3.2.2. Classification of Medical Devices
  • 3.3. Overview of Medical Device Manufacturing
    • 3.3.1. Associated Challenges
    • 3.3.2. Role of Contract Manufacturing Organizations (CMOs)
    • 3.3.3. Role of Automation
  • 3.4. Overview of Medical Device CMOs
  • 3.5. Services Offered by Medical Device CMOs
  • 3.6. Advantages of Medical Device CMOs
  • 3.7. Risks Associated with Outsourcing Manufacturing Operations
  • 3.8. Key Considerations for Selecting a CMO Partner
  • 3.9. Concluding Remarks

4. MEDICAL DEVICE REGULATORY LANDSCAPE

  • 4.1. Chapter Overview
  • 4.2. General Regulatory Guidelines for Medical Devices
  • 4.3. Regulatory Landscape in North America
    • 4.3.1. The US Scenario
      • 4.3.1.1. Regulatory Authority
      • 4.3.1.2. Review / Approval Process
    • 4.3.2. The Canadian Scenario
      • 4.3.2.1. Regulatory Authority
      • 4.3.2.2. Review / Approval Process
  • 4.4. Regulatory Landscape in Europe
    • 4.4.1. Overall Scenario
      • 4.4.1.1. Regulatory Authority
      • 4.4.1.2. Review / Approval Process
    • 4.4.2. Case Study: Brexit -The UK Scenario
  • 4.5. Regulatory Landscape in Asia-Pacific
    • 4.5.1. The Chinese Scenario
      • 4.5.1.1. Regulatory Authority
      • 4.5.1.2. Review / Approval Process
    • 4.5.2. The Japanese Scenario
      • 4.5.2.1. Regulatory Authority
      • 4.5.2.2. Review / Approval Process
    • 4.5.3. The Australian Scenario
      • 4.5.3.1. Regulatory Authority
      • 4.5.3.2. Review / Approval Process
  • 4.6. Comparison of Regional Regulatory Environment

5. MARKET OVERVIEW: THERAPEUTIC DEVICES

  • 5.1. Chapter Overview
  • 5.2. Medical Device CMOs Offering Services for Therapeutic Devices
    • 5.2.1. Analysis by Year of Establishment
    • 5.2.2. Analysis by Size of Employee Base
    • 5.2.3. Analysis by Location of Headquarters
    • 5.2.4. Analysis by Location of Manufacturing Facility
    • 5.2.5. Analysis by Regulatory Certifications / Accreditations
    • 5.2.6. Analysis by Manufacturing Services Offered
    • 5.2.7. Analysis by Post-Production Services Offered
    • 5.2.8. Analysis by Other Services Offered
    • 5.2.9. Analysis by Device Class
    • 5.2.10. Analysis by Type of Material(s) Handled
    • 5.2.11. Analysis by Scale of Operation

6. MARKET OVERVIEW: DIAGNOSTIC DEVICES

  • 6.1. Chapter Overview
  • 6.2. Medical Device CMOs Offering Services for Diagnostic Devices
    • 6.2.1. Analysis by Year of Establishment
    • 6.2.2. Analysis by Size of Employee Base
    • 6.2.3. Analysis by Location of Headquarters
    • 6.2.4. Analysis by Location of Manufacturing Facility
    • 6.2.5. Analysis by Regulatory Certification / Accreditations
    • 6.2.6. Analysis by Manufacturing Services Offered
    • 6.2.7. Analysis by Post-Production Services Offered
    • 6.2.8. Analysis by Other Services Offered
    • 6.2.9. Analysis by Device Class
    • 6.2.10. Analysis by Type of Material(s) Handled
    • 6.2.11. Analysis by Scale of Operation

7. MARKET OVERVIEW: DRUG-DELIVERY DEVICES AND OTHERS

  • 7.1. Chapter Overview
  • 7.2. Medical Device CMOs Offering Services for Drug Delivery Devices
    • 7.2.1. Analysis by Year of Establishment
    • 7.2.2. Analysis by Size of Employee Base
    • 7.2.3. Analysis by Location of Headquarters
    • 7.2.4. Analysis by Location of Manufacturing Facility
    • 7.2.5. Analysis by Regulatory Certifications / Accreditations
    • 7.2.6. Analysis by Manufacturing Services Offered
    • 7.2.7. Analysis by Post-Production Services Offered
    • 7.2.8. Analysis by Other Services Offered
    • 7.2.9. Analysis by Device Class
    • 7.2.10. Analysis by Type of Material(s) Handled
    • 7.2.11. Analysis by Scale of Operation
  • 7.3. Medical Device CMOs Offering Services for Other Devices
    • 7.3.1. Analysis by Year of Establishment
    • 7.3.2. Analysis by Size of Employee Base
    • 7.3.3. Analysis by Location of Headquarters
    • 7.3.4. Analysis by Location of Manufacturing Facility
    • 7.3.5. Analysis by Regulatory Standards of Manufacturing Facility
    • 7.3.6. Analysis by Manufacturing Services Offered
    • 7.3.7. Analysis by Post-Production Services Offered
    • 7.3.8. Analysis by Other Services Offered
    • 7.3.9. Analysis by Device Class
    • 7.3.10. Analysis by Type of Material(s) Handled
    • 7.3.11. Analysis by Scale of Operation

8. BENCHMARK ANALYSIS

  • 8.1. Chapter Overview
  • 8.2. Benchmark Analysis: Methodology
  • 8.3. Region-wise Benchmark Analysis
    • 8.3.1. North America, Peer Group I
    • 8.3.2. North America, Peer Group II
    • 8.3.3. North America, Peer Group III
    • 8.3.4. North America, Peer Group IV
    • 8.3.5. North America, Peer Group V
    • 8.3.6. North America, Peer Group VI
    • 8.3.7. North America, Peer Group VII
    • 8.3.8. Europe, Peer Group VIII
    • 8.3.9. Europe, Peer Group IX
    • 8.3.10. Europe, Peer Group X
    • 8.3.11. Asia, Peer Group XI
    • 8.3.12. Asia, Peer Group XII
    • 8.3.13. Asia, Peer Group XIII
  • 8.4. Concluding Remarks

9. SUPPLY CHAIN ANALYSIS

  • 9.1. Chapter Overview
  • 9.2. Overview of Medical Device Value Chain
    • 9.2.1. Value Chain versus Supply Chain
  • 9.3 Factors Affecting the Medical Device Supply Chain
  • 9.4. Supply Chain Improvement Strategies
  • 9.5. Key Performance Indicators
  • 9.6. Visible Supply Chain and Related Advantages
    • 9.6.1. Augmenting Supply Chain Visibility Through Digitalization
      • 9.6.1.1. Benefits of Digital Supply Chain Management
  • 9.7. Supply Chain Optimization

10. COMPANY PROFILES

  • 10.1. Chapter Overview
  • 10.2. CMOs Headquartered in North America
    • 10.2.1. Cirtec Medical
      • 10.2.1.1. Company Overview
      • 10.2.1.2. Service Portfolio
      • 10.2.1.3. Manufacturing Capabilities and Facilities
      • 10.2.1.4. Future Outlook
    • 10.2.2. DynaFlex Technologies
      • 10.2.2.1. Company Overview
      • 10.2.2.2. Service Portfolio
      • 10.2.2.3. Manufacturing Capabilities and Facilities
      • 10.2.2.4. Future Outlook
    • 10.2.3. I-Tek Medical Technologies
      • 10.2.3.1. Company Overview
      • 10.2.3.2. Service Portfolio
      • 10.2.3.3. Manufacturing Capabilities and Facilities
      • 10.2.3.4. Future Outlook
    • 10.2.4. Keystone Solutions Group
      • 10.2.4.1. Company Overview
      • 10.2.4.2. Service Portfolio
      • 10.2.4.3. Manufacturing Capabilities and Facilities
      • 10.2.4.4. Future Outlook
    • 10.2.5. Oscor
      • 10.2.5.1. Company Overview
      • 10.2.5.2. Service Portfolio
      • 10.2.5.3. Manufacturing Capabilities and Facilities
      • 10.2.5.4. Future Outlook
    • 10.2.6. SMC
      • 10.2.6.1. Company Overview
      • 10.2.6.2. Service Portfolio
      • 10.2.6.3. Manufacturing Capabilities and Facilities
      • 10.2.6.4. Future Outlook
    • 10.2.7. Stellartech
      • 10.2.7.1. Company Overview
      • 10.2.7.2. Service Portfolio
      • 10.2.7.3. Manufacturing Capabilities and Facilities
      • 10.2.7.4. Future Outlook
  • 10.3. CMOs Headquartered in Europe
    • 10.3.1. Creganna Medical
      • 10.3.1.1. Company Overview
      • 10.3.1.2. Service Portfolio
      • 10.3.1.3. Manufacturing Capabilities and Facilities
      • 10.3.1.4. Future Outlook
    • 10.3.2. Europlaz Technologies
      • 10.3.2.1. Company Overview
      • 10.3.2.2. Service Portfolio
      • 10.3.2.3. Manufacturing Capabilities and Facilities
      • 10.3.2.4. Future Outlook
    • 10.3.3. Riverside Medical Packaging
      • 10.3.3.1. Company Overview
      • 10.3.3.2. Service Portfolio
      • 10.3.3.3. Manufacturing Capabilities and Facilities
      • 10.3.3.4. Future Outlook
    • 10.3.4. Synecco
      • 10.3.4.1. Company Overview
      • 10.3.4.2. Service Portfolio
      • 10.3.4.3. Manufacturing Capabilities and Facilities
      • 10.3.4.4. Future Outlook
    • 10.3.5. Trelleborg Sealing Solutions
      • 10.3.5.1. Company Overview
      • 10.3.5.2. Service Portfolio
      • 10.3.5.3. Manufacturing Capabilities and Facilities
      • 10.3.5.4. Future Outlook
  • 10.4. CMOs Headquartered in Asia
    • 10.4.1. Interplex
      • 10.4.1.1. Company Overview
      • 10.4.1.2. Service Portfolio
      • 10.4.1.3. Manufacturing Capabilities and Facilities
      • 10.4.1.4. Future Outlook
    • 10.4.2. Modern Medical
      • 10.4.2.1. Service Portfolio
      • 10.4.2.2. Manufacturing Capabilities and Facilities
      • 10.4.2.3. Future Outlook
    • 10.4.3. Providence Enterprise
      • 10.4.3.1. Company Overview
      • 10.4.3.2. Service Portfolio
      • 10.4.3.3. Manufacturing Capabilities and Facilities
      • 10.4.3.4. Future Outlook
    • 10.4.4. Suzhou Jenitek
      • 10.4.4.1. Company overview
      • 10.4.4.2. Service Portfolio
      • 10.4.4.3. Manufacturing Capabilities and Facilities
      • 10.4.4.4. Future Outlook

11. CLINICAL TRIAL ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Scope and Methodology
  • 11.3. Clinical Trial Analysis: Word Cloud of Trial Titles
  • 11.4. Analysis of Clinical Trials
    • 11.4.1. Analysis by Trial Start Year
    • 11.4.2. Analysis by Trial Status
    • 11.4.3. Analysis by Phase of Development
    • 11.4.4. Analysis by Target Indication
    • 11.4.5. Analysis by Type of Sponsor
    • 11.4.6. Analysis by Geography
    • 11.4.7. Analysis by Trial Start Year and Geography
  • 11.5. Analysis of Enrolled Patient Population
    • 11.5.1. Analysis by Trial Status
    • 11.5.2. Analysis by Phase of Development
    • 11.5.3. Analysis by Geography
  • 11.6. Analysis of Focus Therapeutic Areas
    • 11.6.1. Analysis by Type of Sponsor
    • 11.6.2. Analysis by Geography
      • 11.6.2.1. North American Scenario
      • 11.6.2.2. European Scenario
      • 11.6.2.3. Asia Pacific Scenario
      • 11.6.2.4. Rest of the World Scenario
    • 11.6.3. Cardiovascular Disorders
      • 11.6.3.1. Analysis by Trial Start Year
      • 11.6.3.2. Analysis by Type of Sponsor
      • 11.6.3.3. Analysis by Geography
    • 11.6.4. Oncological Disorders
      • 11.6.4.1. Analysis by Trial Start Year
      • 11.6.4.2. Analysis by Type of Sponsor
      • 11.6.4.3. Analysis by Geography
    • 11.6.5. Central Nervous System (CNS) Disorders
      • 11.6.5.1. Analysis by Trial Start Year
      • 11.6.5.2. Analysis by Type of Sponsor
      • 11.6.5.3. Analysis by Geography
    • 11.6.6. Orthopedic Disorders
      • 11.6.6.1. Analysis by Trial Start Year
      • 11.6.6.2. Analysis by Type of Sponsor
      • 11.6.6.3. Analysis by Geography
    • 11.6.7. Respiratory Disorders
      • 11.6.7.1. Analysis by Trial Start Year
      • 11.6.7.2. Analysis by Type of Sponsor
      • 11.6.7.3. Analysis by Geography

12. MERGERS & ACQUISITIONS

  • 12.1. Chapter Overview
  • 12.2. Acquisition Models
  • 12.3. Medical Device Contract Manufacturing Market: Mergers and Acquisitions
    • 12.3.1. Analysis by Year of Mergers and Acquisitions
    • 12.3.2. Analysis by Type of Acquisition
    • 12.3.3. Most Active Acquirers: Analysis by Number of Acquisitions
    • 12.3.4. Analysis by Key Value Drivers
      • 12.3.4.1. Analysis by Key Value Drivers and Year of Acquisition
    • 12.3.5. Analysis by Type of Device
      • 12.3.5.1. Analysis by Type of Device and Key Value Drivers
    • 12.3.6. Analysis by Therapeutic Area
    • 12.3.7. Analysis by Type of Services Offered
    • 12.3.8. Regional Analysis
      • 12.3.8.1. Continent-wise Distribution
      • 12.3.8.2. Country-wise Distribution
      • 12.3.8.3. Intercontinental and Intracontinental Deals
  • 12.4. Key Acquisitions: Deal Multiples
    • 12.4.1. Relationship between Deal Multiples

13. CASE STUDY: OFFSHORING MEDICAL DEVICE CONTRACT MANUFACTURING

  • 13.1. Chapter Overview
  • 13.2. Emerging Markets: Definitions and Key Regions
  • 13.3. Global Manufacturing Market: Role of Emerging Markets
    • 13.3.1. Contributions to the Automobile Industry
    • 13.3.2. Contributions to the Aerospace and Defence Industries
  • 13.4. Overview of Medical Device Manufacturing in Emerging Markets
    • 13.4.1. The US-Chinese Scenario
    • 13.4.2. Comparative Analysis between Developed Regions and Emerging Markets
    • 13.4.3. Partnerships with Companies in Emerging Markets
  • 13.5. Medical Device-focused Multinational Companies in Emerging Markets
  • 13.6. Medical Device Manufacturing Business Models Used in Emerging Markets
    • 13.6.1. Case Studies
      • 13.6.1.1. Study 1: Overview
        • 13.6.1.1.1. Value Proposition
        • 13.6.1.1.2. Value creation
      • 13.6.1.2. Study 2: Overview
        • 13.6.1.2.1. Value Proposition
        • 13.6.1.2.2. Value creation
  • 13.7. Innovation in Medical Device Industry: Key Challenges
    • 13.7.1. Limitations of In-House Innovation
  • 13.8. Advantages of Establishing Innovation Hubs in Emerging Markets
    • 13.8.1. Challenges and Market Restraints
    • 13.8.2. Strategies to Address Existing Challenges
  • 13.9. Future Perspectives

14. MARKET FORECAST

  • 14.1. Chapter Overview
  • 14.2. Forecast Methodology and Key Assumptions
  • 14.3. Overall Medical Device Contract Manufacturing Market, 2019-2030
    • 14.3.1. Medical Device Contract Manufacturing Market: Distribution by Application Areas, 2019 and 2030
      • 14.3.1.1. Medical Device Contract Manufacturing Market for Therapeutic Devices, 2019-2030
      • 14.3.1.2. Medical Device Contract Manufacturing Market for Diagnostic Devices, 2019-2030
      • 14.3.1.3. Medical Device Contract Manufacturing Market for Drug Delivery Devices, 2019-2030
      • 14.3.1.4. Medical Device Contract Manufacturing Market for Other Devices, 2019-2030
    • 14.3.2. Medical Device Contract Manufacturing Market: Distribution by Device Class, 2019 and 2030
      • 14.3.2.1. Medical Device Contract Manufacturing Market: Class I Devices, 2019 and 2030
      • 14.3.2.2. Medical Device Contract Manufacturing Market: Class II Devices, 2019 and 2030
      • 14.3.2.3. Medical Device Contract Manufacturing Market: Class III Devices, 2019 and 2030
    • 14.3.3. Medical Device Contract Manufacturing Market: Leading Players, 2019-2030
    • 14.3.4. Medical Device Contract Manufacturing Market: Distribution by Therapeutic Area, 2019 and 2030
      • 14.3.4.1. Medical Device Contract Manufacturing Market for Cardiovascular Disorders, 2019-2030
      • 14.3.4.2. Medical Device Contract Manufacturing Market for Disorders, 2019-2030
      • 14.3.4.3. Medical Device Contract Manufacturing Market for Metabolic Disorders, 2019-2030
      • 14.3.4.4. Medical Device Contract Manufacturing Market for Oncological Disorders, 2019-2030
      • 14.3.4.5. Medical Device Contract Manufacturing Market for Orthopedic Disorders, 2019-2030
      • 14.3.4.6. Medical Device Contract Manufacturing Market for Ophthalmic Disorders, 2019-2030
      • 14.3.4.7. Medical Device Contract Manufacturing Market for Pain Disorders, 2019-2030
      • 14.3.4.8. Medical Device Contract Manufacturing Market for Respiratory Disorders, 2019-2030
      • 14.3.4.9. Medical Device Contract Manufacturing Market for Other Therapeutic Areas, 2019-2030
  • 14.4. Medical Device Contract Manufacturing Market: Distribution by Geography, 2019 and 2030
    • 14.4.1. Medical Device Contract Manufacturing Market in North America, 2019-2030
      • 14.4.1.1. Medical Device Contract Manufacturing Market in the US, 2019-2030
      • 14.4.1.2. Medical Device Contract Manufacturing Market in Rest of North America, 2019-2030
      • 14.4.1.3. Medical Device Contract Manufacturing Market in North America, 2019-2030: Class I Devices
      • 14.4.1.4. Medical Device Contract Manufacturing Market in North America, 2019-2030: Class II Devices
      • 14.4.1.5. Medical Device Contract Manufacturing Market in North America, 2019-2030: Class III Devices
      • 14.4.1.6. Medical Device Contract Manufacturing Market in North America for Cardiovascular Disorders, 2019-2030
      • 14.4.1.7. Medical Device Contract Manufacturing Market in North America for CNS Disorders, 2019-2030
      • 14.4.1.8. Medical Device Contract Manufacturing Market in North America for Metabolic Disorders, 2019-2030
      • 14.4.1.9. Medical Device Contract Manufacturing Market in North America for Oncological Disorders, 2019-2030
      • 14.4.1.10. Medical Device Contract Manufacturing Market in North America for Orthopedic Disorders, 2019-2030
      • 14.4.1.11. Medical Device Contract Manufacturing Market in North America for Ophthalmic Disorders, 2019-2030
      • 14.4.1.12. Medical Device Contract Manufacturing Market in North America for Pain Disorders, 2019-2030
      • 14.4.1.13. Medical Device Contract Manufacturing Market in North America for Respiratory Disorders, 2019-2030
      • 14.4.1.14. Medical Device Contract Manufacturing Market in North America for Other Therapeutic Areas, 2019-2030
    • 14.4.2. Medical Device Contract Manufacturing Market in Europe, 2019-2030
      • 14.4.2.1. Medical Device Contract Manufacturing Market in Italy, 2019-2030
      • 14.4.2.2. Medical Device Contract Manufacturing Market in Germany, 2019-2030
      • 14.4.2.3. Medical Device Contract Manufacturing Market in France, 2019-2030
      • 14.4.2.4. Medical Device Contract Manufacturing Market in Spain, 2019-2030
      • 14.4.2.5. Medical Device Contract Manufacturing Market in the UK, 2019-2030
      • 14.4.2.6. Medical Device Contract Manufacturing Market in Rest of Europe, 2019-2030
      • 14.4.2.7. Medical Device Contract Manufacturing Market in Europe: Class I Devices, 2019-2030
      • 14.4.2.8. Medical Device Contract Manufacturing Market in Europe: Class II Devices, 2019-2030
      • 14.4.2.9. Medical Device Contract Manufacturing Market in Europe: Class III Devices, 2019-2030
      • 14.4.2.10. Medical Device Contract Manufacturing Market in Europe for Cardiovascular Disorders, 2019-2030
      • 14.4.2.11. Medical Device Contract Manufacturing Market in Europe for CNS Disorders, 2019-2030
      • 14.4.2.12. Medical Device Contract Manufacturing Market in Europe for Metabolic Disorders, 2019-2030
      • 14.4.2.13. Medical Device Contract Manufacturing Market in Europe for Oncological Disorders, 2019-2030
      • 14.4.2.14. Medical Device Contract Manufacturing Market in Europe for Orthopedic Disorders, 2019-2030
      • 14.4.2.15. Medical Device Contract Manufacturing Market in Europe for Ophthalmic Disorders, 2019-2030
      • 14.4.2.16. Medical Device Contract Manufacturing Market in Europe for Pain Disorders, 2019-2030
      • 14.4.2.17. Medical Device Contract Manufacturing Market in Europe for Respiratory Disorders, 2019-2030
      • 14.4.2.18. Medical Device Contract Manufacturing Market in Europe for Other Therapeutic Areas, 2019-2030
    • 14.4.3. Medical Device Contract Manufacturing Market in Asia and Rest of the World, 2019-2030
      • 14.4.3.1. Medical Device Contract Manufacturing Market in China, 2019-2030
      • 14.4.3.2. Medical Device Contract Manufacturing Market in Japan, 2019-2030
      • 14.4.3.3. Medical Device Contract Manufacturing Market in India, 2019-2030
      • 14.4.3.4. Medical Device Contract Manufacturing Market in Rest of Asia and Rest of the World, 2019-2030
      • 14.4.3.5. Medical Device Contract Manufacturing Market in Asia and Rest of the World: Class I Devices, 2019-2030
      • 14.4.3.6. Medical Device Contract Manufacturing Market in Asia and Rest of the World: Class II Devices, 2019-2030
      • 14.4.3.7. Medical Device Contract Manufacturing Market in Asia and Rest of the World: Class III Devices, 2019-2030
      • 14.4.3.8. Medical Device Contract Manufacturing Market in Asia and Rest of the World for Cardiovascular Disorders, 2019-2030
      • 14.4.3.9. Medical Device Contract Manufacturing Market in Asia and Rest of the World for CNS Disorders, 2019-2030
      • 14.4.3.10. Medical Device Contract Manufacturing Market in Asia and Rest of the World for Metabolic Disorders, 2019-2030
      • 14.4.3.11. Medical Device Contract Manufacturing Market in Asia and Rest of the World for Oncological Disorders, 2019-2030
      • 14.4.3.12. Medical Device Contract Manufacturing Market in Asia and Rest of the World for Orthopedic Disorders, 2019-2030
      • 14.4.3.13. Medical Device Contract Manufacturing Market in Asia and Rest of the World for Ophthalmic Disorders, 2019-2030
      • 14.4.3.14. Medical Device Contract Manufacturing Market in Asia and Rest of the World for Pain Disorders, 2019-2030
      • 14.4.3.15. Medical Device Contract Manufacturing Market in Asia and Rest of the World for Respiratory Disorders, 2019-2030
      • 14.4.3.16. Medical Device Contract Manufacturing Market in Asia and Rest of the World for Other Therapeutic Areas, 2019-2030

15. SWOT ANALYSIS

  • 15.1. Chapter Overview
  • 15.2. Strengths
  • 15.3. Weaknesses
  • 15.4. Opportunities
  • 15.5. Threats
  • 15.6. Concluding Remarks

16. CONCLUSION

17. SURVEY / INTERVIEW TRANSCRIPTS

18. APPENDIX 1: TABULATED DATA

19. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Figures

  • Figure 3.1. Historical Evolution of Medical Devices
  • Figure 3.2. Medical Device Manufacturing Process
  • Figure 3.3. Challenges Associated with Medical Device Manufacturing
  • Figure 3.4. Advantages of Automation
  • Figure 3.5. Services Offered by CMOs
  • Figure 3.6. Advantages of Outsourcing to CMOs
  • Figure 3.7. Risks Associated with Outsourcing to CMOs
  • Figure 3.8. Key Considerations for Selecting a CMO Partner
  • Figure 4.1. US FDA: Review / Approval Process
  • Figure 4.2. Health Canada: Review / Approval Process
  • Figure 4.3. Summary of CE Marking Process
  • Figure 4.4. Pharmaceuticals and Medical Devices Agency: Review / Approval Process
  • Figure 4.5. China Food and Drug Administration: Review / Approval Process
  • Figure 4.6. Therapeutic Goods Administration: Review / Approval Process
  • Figure 4.7. Bubble Analysis: Regional Regulatory Environment
  • Figure 5.1. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Year of Establishment
  • Figure 5.2. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Size of Employee Base
  • Figure 5.3. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Location of Headquarters
  • Figure 5.4. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Location of Manufacturing Facility
  • Figure 5.5. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Regulatory Certifications / Accreditations
  • Figure 5.6. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Manufacturing Services Offered
  • Figure 5.7. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Post-Production Services Offered
  • Figure 5.8. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Other Services Offered
  • Figure 5.9. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Device Class
  • Figure 5.10. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Type of Material(s) Handled
  • Figure 5.11. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Scale of Operation
  • Figure 6.1. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Year of Establishment
  • Figure 6.2. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Size of Employee Base
  • Figure 6.3. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Location of Headquarters
  • Figure 6.4. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Location of Manufacturing Facility
  • Figure 6.5. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Regulatory Certifications / Accreditations
  • Figure 6.6. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Manufacturing Services Offered
  • Figure 6.7. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Post-Production Services Offered
  • Figure 6.8. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Other Services Offered
  • Figure 6.9. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Device Class
  • Figure 6.10. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Type of Material(s) Handled
  • Figure 6.11. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Scale of Operation
  • Figure 7.1. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Year of Establishment
  • Figure 7.2. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Size of Employee Base
  • Figure 7.3. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Location of Headquarters
  • Figure 7.4. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Location of Manufacturing Facility
  • Figure 7.5. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Regulatory Certifications / Accreditations
  • Figure 7.6. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Manufacturing Services Offered
  • Figure 7.7. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Post-Production Services Offered
  • Figure 7.8. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Other Services Offered
  • Figure 7.9. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Device Class
  • Figure 7.10. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Type of Material(s) Handled
  • Figure 7.11. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Scale of Operation
  • Figure 7.12. Medical Device CMOs Offering Services for Other Devices: Distribution by Year of Establishment
  • Figure 7.13. Medical Device CMOs Offering Services for Other Devices: Distribution by Size of Employee Base
  • Figure 7.14. Medical Device CMOs Offering Services for Other Devices: Distribution by Location of Headquarters
  • Figure 7.15. Medical Device CMOs Offering Services for Other Devices: Distribution by Location of Manufacturing Facility
  • Figure 7.16. Medical Device CMOs Offering Services for Other Devices: Distribution by Regulatory Certifications / Accreditations
  • Figure 7.17. Medical Device CMOs Offering Services for Other Devices: Distribution by Manufacturing Services Offered
  • Figure 7.18. Medical Device CMOs Offering Services for Other Devices: Distribution by Post-Production Services Offered
  • Figure 7.19. Medical Device CMOs Offering Services for Other Devices: Distribution by Other Services Offered
  • Figure 7.20. Medical Device CMOs Offering Services for Other Devices: Distribution by Device Class
  • Figure 7.21. Medical Device CMOs Offering Services for Other Devices: Distribution by Type of Material(s) Handled
  • Figure 7.22. Medical Device CMOs Offering Services for Other Devices: Distribution by Scale of Operation
  • Figure 8.1. Benchmark Analysis: Distribution by Region and Size of Employee Base
  • Figure 8.2. Benchmark Analysis: North America, Peer Group I
  • Figure 8.3. Benchmark Analysis: North America, Peer Group II
  • Figure 8.4. Benchmark Analysis: North America, Peer Group III
  • Figure 8.5. Benchmark Analysis: North America, Peer Group IV
  • Figure 8.6. Benchmark Analysis: North America, Peer Group V
  • Figure 8.7. Benchmark Analysis: North America, Peer Group VI
  • Figure 8.8. Benchmark Analysis: North America, Peer Group VII
  • Figure 8.9. Benchmark Analysis: Europe, Peer Group VIII
  • Figure 8.10. Benchmark Analysis: Europe, Peer Group IX
  • Figure 8.11. Benchmark Analysis: Europe, Peer Group X
  • Figure 8.12. Benchmark Analysis: Asia, Peer Group XI
  • Figure 8.13. Benchmark Analysis: Asia, Peer Group XII
  • Figure 8.14. Benchmark Analysis: Asia, Peer Group XIII
  • Figure 8.15. Benchmark Analysis: Comparison Across Peer Groups
  • Figure 10.1. Cirtec Medical: Production-related Service Portfolio
  • Figure 10.2. Cirtec Medical: Post-production Service Portfolio
  • Figure 10.3. DynaFlex Technologies: Production-related Service Portfolio
  • Figure 10.4. DynaFlex Technologies: Post-production Service Portfolio
  • Figure 10.5. I-Tek Medical Technologies: Production-related Service Portfolio
  • Figure 10.6. I-Tek Medical Technologies: Post-production Service Portfolio
  • Figure 10.7. Keystone Solutions Group: Production-related Service Portfolio
  • Figure 10.8. Keystone Solutions Group: Post-production Service Portfolio
  • Figure 10.9. Oscor: Production-related Service Portfolio
  • Figure 10.10. Oscor: Post-production Service Portfolio
  • Figure 10.11. SMC: Production-related Service Portfolio
  • Figure 10.12. SMC: Post-production Service Portfolio
  • Figure 10.13. Stellartech: Production-related Service Portfolio
  • Figure 10.14. Stellartech: Post-production Service Portfolio
  • Figure 10.15. Creganna Medical: Production-related Service Portfolio
  • Figure 10.16. Creganna Medical: Post-production Service Portfolio
  • Figure 10.17. Europlaz Technologies: Production-related Service Portfolio
  • Figure 10.18. Europlaz Technologies: Post-production Service Portfolio
  • Figure 10.19. Riverside Medical Packaging: Production-related Service Portfolio
  • Figure 10.20. Riverside Medical Packaging: Post-production Service Portfolio
  • Figure 10.21. Synecco: Production-related Service Portfolio
  • Figure 10.22. Synecco: Post-production Service Portfolio
  • Figure 10.23. Trelleborg Sealing Solutions: Production-related Service Portfolio
  • Figure 10.24. Trelleborg Sealing Solutions: Post-production Service Portfolio
  • Figure 10.25. Interplex: Production-related Service Portfolio
  • Figure 10.26. Interplex: Post-production Service Portfolio
  • Figure 10.27. Modern Medical: Production-related Service Portfolio
  • Figure 10.28. Modern Medical: Post-production Service Portfolio
  • Figure 10.29. Providence Enterprise: Production-related Service Portfolio
  • Figure 10.30. Providence Enterprise: Post-production Service Portfolio
  • Figure 10.31. Suzhou Jenitek: Production-related Service Portfolio
  • Figure 10.32. Suzhou Jenitek: Post-production Service Portfolio
  • Figure 11.1. Clinical Trial Analysis: Word Cloud of Trial Titles
  • Figure 11.2. Clinical Trial Analysis: Distribution by Trial Start Year, 2013-Q1 2019
  • Figure 11.3. Clinical Trial Analysis: Distribution by Trial Status
  • Figure 11.4. Clinical Trial Analysis: Distribution by Phase of Development
  • Figure 11.5. Clinical Trial Analysis: Top 10 Target Indications
  • Figure 11.6. Clinical Trial Analysis: Distribution by Type of Sponsor
  • Figure 11.7. Clinical Trial Analysis: Distribution by Geography
  • Figure 11.8. Clinical Trial Analysis: Distribution by Trial Start Year and Geography (2013-2018)
  • Figure 11.9. Enrolled Patient Population: Distribution by Trial Status
  • Figure 11.10. Enrolled Patient Population: Distribution by Phase of Development
  • Figure 11.11. Enrolled Patient Population: Distribution by Geography
  • Figure 11.12. Clinical Trial Analysis: Distribution by Focus Therapeutic Areas
  • Figure 11.13. Heat Map Analysis: Emerging Therapeutic Areas
  • Figure 11.14. Clinical Trial Analysis: Distribution by Type of Sponsor and Top 10 Therapeutic Areas
  • Figure 11.15. Clinical Trial Analysis: Prominent Therapeutic Areas in North America
  • Figure 11.16. Clinical Trial Analysis: Prominent Therapeutic Areas in Europe
  • Figure 11.17. Clinical Trial Analysis: Prominent Therapeutic Areas in Asia Pacific
  • Figure 11.18. Clinical Trial Analysis: Prominent Therapeutic Areas in Rest of the World
  • Figure 11.19. Clinical Trials for Cardiovascular Disorders: Distribution by Trial Start Year, 2013-Q1 2019
  • Figure 11.20. Clinical Trials for Cardiovascular Disorders: Distribution by Sponsor Type
  • Figure 11.21. Clinical Trials for Cardiovascular Disorders: Distribution by Geography
  • Figure 11.22. Clinical Trials for Oncological Disorders: Distribution of Trials by Start Year, 2013-Q1 2019
  • Figure 11.23. Clinical Trials for Oncological Disorders: Distribution by Sponsor Type
  • Figure 11.24. Clinical Trials for Oncological Disorders: Distribution by Geography
  • Figure 11.25. Clinical Trials for CNS Disorders: Distribution of Trials by Start Year, 2013-Q1 2019
  • Figure 11.26. Clinical Trials for CNS Disorders: Distribution by Sponsor Type
  • Figure 11.27. Clinical Trials for CNS Disorders: Distribution by Geography
  • Figure 11.28. Clinical Trials for Orthopedic Disorders: Distribution of Trials by Start Year, 2013-Q1 2019
  • Figure 11.29. Clinical Trials for Orthopedic Disorders: Distribution by Sponsor Type
  • Figure 11.30. Clinical Trials for Orthopedic Disorders: Distribution by Geography
  • Figure 11.31. Clinical Trials for Respiratory Disorders: Distribution of Trials by Start Year, 2013-Q1 2019
  • Figure 11.32. Clinical Trials for Respiratory Disorders: Distribution by Sponsor Type
  • Figure 11.33. Clinical Trials for Respiratory Disorders: Distribution by Geography
  • Figure 12.1. Mergers and Acquisitions: Year-Wise Cumulative Trend (2013- 2019)
  • Figure 12.2. Mergers and Acquisitions: Distribution by Type of Acquisitions
  • Figure 12.3. Most Active Acquirers: Distribution by Number of Acquisitions
  • Figure 12.4. Mergers and Acquisitions: Key Value Drivers
  • Figure 12.5. Mergers and Acquisitions: Distribution by Key Value Drivers and Year of Acquisition
  • Figure 12.6. Mergers and Acquisitions: Distribution by Type of Device
  • Figure 12.7. Heat Map Analysis: Type of Devices and Key Value Drivers
  • Figure 12.8. Mergers and Acquisitions: Distribution by Therapeutic Area
  • Figure 12.9. Mergers and Acquisitions: Distribution by Services Offered
  • Figure 12.10. Acquisitions: Continental Distribution
  • Figure 12.11. Acquisitions: Country-wise Distribution
  • Figure 12.12. Acquisitions: Intercontinental and Intracontinental Acquisitions
  • Figure 12.13. Mergers and Acquisitions: Relationship between Deal Multiples
  • Figure 13.1. Prominent Emerging Markets
  • Figure 13.2. Recommendations to Optimize Manufacturing Strategies
  • Figure 14.1. Overall Medical Device CMOs Market, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.2. Medical Device CMOs Market for Therapeutic Devices, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.3. Medical Device CMOs Market for Diagnostic Devices, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.4. Medical Device CMOs Market for Drug Delivery Devices, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.5. Medical Device CMOs Market for Other Devices, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.6. Medical Device CMOs Market for Class I Devices, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.7. Medical Device CMOs Market for Class II Devices, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.8. Medical Device CMOs Market for Class III Devices, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.9. Medical Device CMOs Market: Leading Players, 2019-2030 (USD Billion)
  • Figure 14.10. Medical Device CMOs Market for Cardiovascular Disorders, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.11. Medical Device CMOs Market for CNS Disorders, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.12. Medical Device CMOs Market for Metabolic Disorders, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.13. Medical Device CMOs Market for Oncological Disorders, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.14. Medical Device CMOs Market for Orthopedic Disorders, Base Scenario, 2019-2030 (USD
  • Figure 14.15. Medical Device CMOs Market for Ophthalmic Disorders, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.16. Medical Device CMOs Market for Pain Disorders, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.17. Medical Device CMOs Market for Respiratory Disorders, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.18. Medical Device CMOs Market for Other Therapeutic Areas, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.19. Medical Device CMOs Market in North America, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.20. Medical Device CMOs Market in the US, 2019-2030 (USD Billion)
  • Figure 14.21. Medical Device CMOs Market in Rest of North America, 2019-2030 (USD Billion)
  • Figure 14.22. Medical Device CMOs Market for Class I Devices in North America, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.23. Medical Device CMOs Market for Class II Devices in North America, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.24. Medical Device CMOs Market for Class III Devices in North America, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.25. Medical Device CMOs Market for Cardiovascular Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.26. Medical Device CMOs Market for CNS Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.27. Medical Device CMOs Market for Metabolic Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.28. Medical Device CMOs Market for Oncological Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.29. Medical Device CMOs Market for Orthopedic Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.30. Medical Device CMOs Market for Ophthalmic Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.31. Medical Device CMOs Market for Pain Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.32. Medical Device CMOs Market for Respiratory Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.33. Medical Device CMOs Market for Other Therapeutic Areas in North America, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.34. Medical Device CMOs Market in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.35. Medical Device CMOs Market in Italy, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.36. Medical Device CMOs Market in Germany, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.37. Medical Device CMOs Market in France, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.38. Medical Device CMOs Market in Spain, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.39. Medical Device CMOs Market in the UK, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.40. Medical Device CMOs Market in Rest of Europe, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.41. Medical Device CMOs Market for Class I Devices in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.42. Medical Device CMOs Market for Class II Devices in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.43. Medical Device CMOs Market for Class III Devices in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.44. Medical Device CMOs Market for Cardiovascular Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.45. Medical Device CMOs Market for CNS Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.46. Medical Device CMOs Market for Metabolic Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.47. Medical Device CMOs Market of Oncological Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.48. Medical Device CMOs Market for Orthopedic Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.49. Medical Device CMOs Market for Ophthalmic Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.50. Medical Device CMOs Market for Pain Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.51. Medical Device CMOs Market for Respiratory Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.52. Medical Device CMOs Market for Other Therapeutic Areas in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.53. Medical Device CMOs Market in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.54. Medical Device CMOs Market in China, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.55. Medical Device CMOs Market in Japan, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.56. Medical Device CMOs Market in India, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.57. Medical Device CMOs Market in Rest of Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.58. Medical Device CMOs Market for Class I Devices in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.59. Medical Device CMOs Market for Class II Devices in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.60. Medical Device CMOs Market for Class III Devices in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.61. Medical Device CMOs Market for Cardiovascular Disorders in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.62. Medical Device CMOs Market for CNS Disorders in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.63. Medical Device CMOs Market for Metabolic Disorders in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.64. Medical Device CMOs Market for Oncological Disorders in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.65. Medical Device CMOs Market for Orthopedic Disorders in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.66. Medical Device CMOs Market for Ophthalmic Disorders in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.67. Medical Device CMOs Market for Pain Disorders in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.68. Medical Device CMOs Market for Respiratory Disorders in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Figure 14.69. Medical Device CMOs Market for Other Therapeutic Areas in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Figure 15.1. Medical Device Contract Manufacturing SWOT Analysis: Overview
  • Figure 15.2. Comparison of SWOT Factors: Harvey Ball Analysis

List of Tables

  • Table 4.1. Device Classification: US
  • Table 4.2. Device Classification: Canada
  • Table 4.3. HTA Processes in Canada: Provincial Requirements
  • Table 4.4. Regulatory Bodies in EU5 Countries
  • Table 4.5. Device Classification: Europe
  • Table 4.6. List of CE Directives in Europe
  • Table 4.7. Conformity Assessment Modules in Europe
  • Table 4.8. Device Classification: Japan
  • Table 4.9. Device Classification: China
  • Table 4.10. Device Classification: Australia
  • Table 4.11. Medical Devices: Regulatory Landscape Summary
  • Table 5.1. List of Medical Device CMOs Offering Services for Therapeutic Devices
  • Table 5.2. Medical Device CMOs Offering Services for Therapeutic Devices: Information on Regulatory Certifications / Accreditations
  • Table 5.3. Medical Device CMOs Offering Services for Therapeutic Devices: Information on Manufacturing Services
  • Table 5.4. Medical Device CMOs Offering Services for Therapeutic Devices: Information on Post-Production Services
  • Table 5.5. Medical Device CMOs Offering Services for Therapeutic Devices: Information on Other Services
  • Table 5.6. Medical Device CMOs Offering Services for Therapeutic Devices: Information on Device Class
  • Table 5.7. Medical Device CMOs Offering Services for Therapeutic Devices: Information on Type of Material(s) Handled
  • Table 5.8. Medical Device CMOs Offering Services for Therapeutic Devices: Information on Scale of Operation
  • Table 6.1. List of Medical Device CMOs Offering Services for Diagnostic Devices
  • Table 6.2. Medical Device CMOs Offering Services for Diagnostic Devices: Information on Regulatory Certifications / Accreditations
  • Table 6.3. Medical Device CMOs Offering Services for Diagnostic Devices: Information on Manufacturing Services
  • Table 6.4. Medical Device CMOs Offering Services for Diagnostic Devices: Information on Post-Production Services
  • Table 6.5. Medical Device CMOs Offering Services for Diagnostic Devices: Information on Other Services
  • Table 6.6. Medical Device CMOs Offering Services for Diagnostic Devices: Information on Device Class
  • Table 6.7. Medical Device CMOs Offering Services for Diagnostic Devices: Information on Type of Material(s) Handled
  • Table 6.8. Medical Device CMOs Offering Services for Diagnostic Devices: Information on Scale of Operations
  • Table 7.1. List of Medical Device CMOs Offering Services for Drug Delivery Devices
  • Table 7.2. Medical Device CMOs Offering Services for Drug Delivery Devices: Information on Regulatory Certifications / Accreditations
  • Table 7.3. Medical Device CMOs Offering Services for Drug Delivery Devices: Information on Manufacturing Services
  • Table 7.4. Medical Device CMOs Offering Services for Drug Delivery Devices: Information on Post-Production Services
  • Table 7.5. Medical Device CMOs Offering Services for Drug Delivery Devices: Information on Other Services
  • Table 7.6. Medical Device CMOs Offering Services for Drug Delivery Devices: Information on Device Class
  • Table 7.7. Medical Device CMOs Offering Services for Drug Delivery Devices: Information on Type of Material(s) Handled
  • Table 7.8. Medical Device CMOs Offering Services for Drug Delivery Devices: Information on Scale of Operations
  • Table 7.9. List of Medical Device CMOs Offering Services for Other Devices
  • Table 7.10. Medical Device CMOs Offering Services for Other Devices: Information on Regulatory Certifications / Accreditations
  • Table 7.11. Medical Device CMOs Offering Services for Other Devices: Information on Manufacturing Services
  • Table 7.12. Medical Device CMOs Offering Services for Other Devices: Information on Post-Production Services
  • Table 7.13. Medical Device CMOs Offering Services for Other Devices: Information on Other Services
  • Table 7.14. Medical Device CMOs Offering Services for Other Devices: Information on Device Class
  • Table 7.15. Medical Device CMOs Offering Services for Other Devices: Information on Type of Material(s) Handled
  • Table 7.16. Medical Device CMOs Offering Services for Other Devices: Information on Scale of Operations
  • Table 8.1. Benchmark Analysis: Peer Groups
  • Table 10.1. Cirtec Medical: Company Overview
  • Table 10.2. DynaFlex Technologies: Company Overview
  • Table 10.3. I-Tek Medical Technologies: Company Overview
  • Table 10.4. Keystone Solutions Group: Company Overview
  • Table 10.5. Oscor: Company Overview
  • Table 10.6. SMC: Company Overview
  • Table 10.7. Stellartech: Company Overview
  • Table 10.8. Creganna Medical: Company Overview
  • Table 10.9. Europlaz Technologies: Company Overview
  • Table 10.10. Riverside Medical Packaging: Company Overview
  • Table 10.11. Synecco: Post-production Company Overview
  • Table 10.12. Trelleborg Sealing Solutions: Company Overview
  • Table 10.13. Interplex: Company Overview
  • Table 10.14. Modern Medical: Company Overview
  • Table 10.15. Providence Enterprise: Company Overview
  • Table 10.16. Suzhou Jenitek: Company Overview
  • Table 12.1. Medical Device Contract Manufacturing: List of Mergers and Acquisitions, 2014 - 2019
  • Table 12.2. Mergers and Acquisitions: Key Value Drivers and Type of Devices, 2014- 2019
  • Table 12.3. Mergers and Acquisitions: Deal Multiples, 2013- 2018
  • Table 13.1. Comparative Analysis between Developed and Developing Nations
  • Table 13.2. Medtech A: Company Overview
  • Table 13.3. Medtech A: Operational Values
  • Table 13.4. Medtech B: Company Overview
  • Table 13.5. Medtech A: Operational Values
  • Table 18.1. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Year of Establishment
  • Table 18.2. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Size of Employee Base
  • Table 18.3. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Location of Headquarters
  • Table 18.4. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Location of Manufacturing Facility
  • Table 18.5. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Regulatory Certifications / Accreditations
  • Table 18.6. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Manufacturing Services Offered
  • Table 18.7. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Post-Production Services Offered
  • Table 18.8. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Other Services Offered
  • Table 18.9. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Device Class
  • Table 18.10. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Type of Material(s) Handled
  • Table 18.11. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Scale of Operation
  • Table 18.12. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Year of Establishment
  • Table 18.13. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Size of Employee Base
  • Table 18.14. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Location of Headquarters
  • Table 18.15. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Location of Manufacturing Facility
  • Table 18.16. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Regulatory Certifications / Accreditations
  • Table 18.17. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Manufacturing Services Offered
  • Table 18.18. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Post-Production Services Offered
  • Table 18.19. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Other Services Offered
  • Table 18.20. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Device Class
  • Table 18.21. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Type of Material(s) Handled
  • Table 18.22. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Scale of Operation
  • Table 18.23. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Year of Establishment
  • Table 18.24. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Size of Employee Base
  • Table 18.25. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Location of Headquarters
  • Table 18.26. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Location of Manufacturing Facility
  • Table 18.27. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Regulatory Certifications / Accreditations
  • Table 18.28. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Manufacturing Services Offered
  • Table 18.29. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Post-Production Services Offered
  • Table 18.30. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Other Services Offered
  • Table 18.31. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Device Class
  • Table 18.32. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Type of Material(s) Handled
  • Table 18.33. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Scale of Operation
  • Table 18.34. Medical Device CMOs Offering Services for Other Devices: Distribution by Year of Establishment
  • Table 18.35. Medical Device CMOs Offering Services for Other Devices: Distribution by Size of Employee Base
  • Table 18.36. Medical Device CMOs Offering Services for Other Devices: Distribution by Location of Headquarters
  • Table 18.37. Medical Device CMOs Offering Services for Other Devices: Distribution by Location of Manufacturing Facility
  • Table 18.38. Medical Device CMOs Offering Services for Other Devices: Distribution by Regulatory Certifications / Accreditations
  • Table 18.39. Medical Device CMOs Offering Services for Other Devices: Distribution by Manufacturing Services Offered
  • Table 18.40. Medical Device CMOs Offering Services for Other Devices: Distribution by Post-Production Services Offered
  • Table 18.41. Medical Device CMOs Offering Services for Other Devices: Distribution by Other Services Offered
  • Table 18.42. Medical Device CMOs Offering Services for Other Devices: Distribution by Device Class
  • Table 18.43. Medical Device CMOs Offering Services for Other Devices: Distribution by Type of Material(s) Handled
  • Table 18.44. Medical Device CMOs Offering Services for Other Devices: Distribution by Scale of Operation
  • Table 18.45. Benchmark Analysis: Distribution by Region and Size of Employee Base
  • Table 18.46. Clinical Trial Analysis: Distribution by Trial Start Year, 2013-Q1 2019
  • Table 18.47. Clinical Trial Analysis: Distribution by Trial Status
  • Table 18.48. Clinical Trial Analysis: Distribution by Phase of Development
  • Table 18.49. Clinical Trial Analysis: Top 10 Target Indication
  • Table 18.50. Clinical Trial Analysis: Distribution by Sponsor Type
  • Table 18.51. Clinical Trial Analysis: Distribution by Trial Start Year and Geography (2013-2018)
  • Table 18.52. Enrolled Patient Population: Distribution by Trial Status
  • Table 18.53. Enrolled Patient Population: Distribution by Phase of Development
  • Table 18.54. Clinical Trial Analysis: Distribution by Focus Therapeutic Areas
  • Table 18.55. Heat Map Analysis: Emerging Therapeutic Areas
  • Table 18.56. Clinical Trial Analysis: Distribution by Type of Sponsor and Top 10 Therapeutic Areas
  • Table 18.57. Clinical Trial Analysis: Prominent Therapeutic Areas in North America
  • Table 18.58. Clinical Trial Analysis: Prominent Therapeutic Areas in Europe
  • Table 18.59. Clinical Trial Analysis: Prominent Therapeutic Areas in Asia Pacific
  • Table 18.60. Clinical Trial Analysis: Prominent Therapeutic Areas in Rest of the World
  • Table 18.61. Clinical Trials for Cardiovascular Disorders: Distribution by Trial Start Year, 2013-Q1 2019
  • Table 18.62. Clinical Trials for Cardiovascular Disorders: Distribution by Sponsor Type
  • Table 18.63. Clinical Trials for Cardiovascular Disorders: Distribution by Geography
  • Table 18.64. Clinical Trials for Oncological Disorders: Distribution of Trials by Start Year, 2013-Q1 2019
  • Table 18.65. Clinical Trials for Oncological Disorders: Distribution by Sponsor Type
  • Table 18.66. Clinical Trials for Oncological Disorders: Distribution by Geography
  • Table 18.67. Clinical Trials for CNS Disorders: Distribution of Trials by Start Year, 2013-Q1 2019
  • Table 18.68. Clinical Trials for CNS Disorders: Distribution by Sponsor Type
  • Table 18.69. Clinical Trials for CNS Disorders: Distribution by Geography
  • Table 18.70. Clinical Trials for Orthopedic Disorders: Distribution of Trials by Start Year, 2013-Q1 2019
  • Table 18.71. Clinical Trials for Orthopedic Disorders: Distribution by Sponsor Type
  • Table 18.72. Clinical Trials for Orthopedic Disorders: Distribution by Geography
  • Table 18.73. Clinical Trials for Respiratory Disorders: Distribution of Trials by Start Year, 2013-Q1 2019
  • Table 18.74. Clinical Trials for Respiratory Disorders: Distribution by Sponsor Type
  • Table 18.75. Clinical Trials for Respiratory Disorders: Distribution by Geography
  • Table 18.76. Mergers and Acquisitions: Year-Wise Cumulative Trend (2013- 2019)
  • Table 18.77. Mergers and Acquisitions: Distribution by Type of Acquisitions
  • Table 18.78. Acquisitions: Most Active Acquirers
  • Table 18.79. Mergers and Acquisitions: Key Value Drivers
  • Table 18.80. Mergers and Acquisitions: Distribution by Key Value Drivers and Year of Acquisition
  • Table 18.81. Mergers and Acquisitions: Distribution by Type of Devices
  • Table 18.82. Mergers and Acquisitions: Distribution by Therapeutic Area
  • Table 18.83. Mergers and Acquisitions: Distribution by Services Offered
  • Table 18.84. Acquisitions: Country-wise Distribution
  • Table 18.85. Overall Medical Device CMOs Market, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.86. Medical Device CMOs Market for Therapeutic Devices, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.87. Medical Device CMOs Market for Diagnostic Devices, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.88. Medical Device CMOs Market for Drug Delivery Devices, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.89. Medical Device CMOs Market for Other Devices, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.90. Medical Device CMOs Market for Class I Devices, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.91. Medical Device CMOs Market for Class II Devices, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.92. Medical Device CMOs Market for Class III Devices, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.93. Medical Device CMOs Market: Leading Players, 2019-2030 (USD Billion)
  • Table 18.94. Medical Device CMOs Market for Cardiovascular Disorders, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.95. Medical Device CMOs Market for CNS Disorders, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.96. Medical Device CMOs Market for Metabolic Disorders, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.97. Medical Device CMOs Market for Oncological Disorders, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.98. Medical Device CMOs Market for Orthopedic Disorders, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.99. Medical Device CMOs Market for Ophthalmic Disorders, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.100. Medical Device CMOs Market for Pain Disorders, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.101. Medical Device CMOs Market for Respiratory Disorders, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.102. Medical Device CMOs Market for Other Therapeutic Areas, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.103. Medical Device CMOs Market in North America, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.104. Medical Device CMOs Market in the US, 2019-2030 (USD Billion)
  • Table 18.105. Medical Device CMOs Market in Rest of North America, 2019-2030 (USD Billion)
  • Table 18.106. Medical Device CMOs Market for Class I Devices in North America, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.107. Medical Device CMOs Market for Class II Devices in North America, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.108. Medical Device CMOs Market for Class III Devices in North America, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.109. Medical Device CMOs Market for Cardiovascular Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.110. Medical Device CMOs Market for CNS Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.111. Medical Device CMOs Market for Metabolic Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.112. Medical Device CMOs Market for Oncological Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.113. Medical Device CMOs Market for Orthopedic Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.114. Medical Device CMOs Market for Ophthalmic Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.115. Medical Device CMOs Market for Pain Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.116. Medical Device CMOs Market for Respiratory Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.117. Medical Device CMOs Market for Other Therapeutic Areas in North America, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.118. Medical Device CMOs Market in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.119. Medical Device CMOs Market in Italy, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.120. Medical Device CMOs Market in Germany, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.121. Medical Device CMOs Market in France, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.122. Medical Device CMOs Market in Spain, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.123. Medical Device CMOs Market in the UK, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.124. Medical Device CMOs Market in Rest of Europe, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.125. Medical Device CMOs Market for Class I Devices in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.126. Medical Device CMOs Market for Class II Devices in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.127. Medical Device CMOs Market for Class III Devices in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.128. Medical Device CMOs Market for Cardiovascular Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.129. Medical Device CMOs Market for CNS Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.130. Medical Device CMOs Market for Metabolic Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.131. Medical Device CMOs Market of Oncological Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.132. Medical Device CMOs Market for Orthopedic Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.133. Medical Device CMOs Market for Ophthalmic Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.134. Medical Device CMOs Market for Pain Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.135. Medical Device CMOs Market for Respiratory Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.136. Medical Device CMOs Market for Other Therapeutic Areas in Europe, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.137. Medical Device CMOs Market in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.138. Medical Device CMOs Market in China, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.139. Medical Device CMOs Market in Japan, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.140. Medical Device CMOs Market in India, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.141. Medical Device CMOs Market in Rest of Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.142. Medical Device CMOs Market for Class I Devices in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.143. Medical Device CMOs Market for Class II Devices in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.144. Medical Device CMOs Market for Class III Devices in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.145. Medical Device CMOs Market for Cardiovascular Disorders in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.146. Medical Device CMOs Market for CNS Disorders in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.147. Medical Device CMOs Market for Metabolic Disorders in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.148. Medical Device CMOs Market for Oncological Disorders in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.149. Medical Device CMOs Market for Orthopedic Disorders in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.150. Medical Device CMOs Market for Ophthalmic Disorders in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.151. Medical Device CMOs Market for Pain Disorders in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.152. Medical Device CMOs Market for Respiratory Disorders in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)
  • Table 18.153. Medical Device CMOs Market for Other Therapeutic Areas in Asia and Rest of the World, Base Scenario, 2019-2030 (USD Billion)

Listed Companies

The following companies and organizations have been mentioned in the report.

  • 1. 3D Medical Manufacturing (acquired by Tecomet)
  • 2. 3i Group
  • 3. Accellent
  • 4. Access Point Technologies
  • 5. AccuMED
  • 6. Adroit Medical Systems
  • 7. Aduro Laser (acquired by Resonetics)
  • 8. Advanced Precision (acquired by ARCH Global Precision)
  • 9. AdvancedCath (acquired by TE Connectivity)
  • 10. Advant Medical
  • 11. AEA Investors
  • 12. AIM Plastics (acquired by Medbio)
  • 13. AJ Plastic Components
  • 14. Alcoa
  • 15. Alhenia (acquired by Orchid Orthopedic Solutions)
  • 16. Alpha Manufacturing & Design
  • 17. AMETEK
  • 18. Amsino
  • 19. Andocor
  • 20. Angiplast
  • 21. Apex Medical Technologies
  • 22. Apex Resource Technologies (acquired by Spectrum Plastics Group)
  • 23. Apollo Medical Extrusion (acquired by Kelpac Medical)
  • 24. Aran Biomedical
  • 25. Arcamed
  • 26. ARCH Global Precision
  • 27. Arcor Laser Services (acquired by Cadence)
  • 28. Ardiem Medical
  • 29. Argon Medical Devices
  • 30. AristoTech Medical Forgings and Services
  • 31. Arlington Capital Partners
  • 32. Arrotek
  • 33. Arrow Medical
  • 34. Artifex Solutions
  • 35. Asteelflash
  • 36. Astorg
  • 37. Atrion
  • 38. Aubrey Group (acquired by Sparton)
  • 39. Avalign Technologies
  • 40. Avenue Mould Solutions (acquired by GW Plastics)
  • 41. Aviton Care
  • 42. Axcesor
  • 43. Axenics
  • 44. B&A Health
  • 45. Balda
  • 46. Beldico
  • 47. Bemis
  • 48. Big River Engineering and Manufacturing
  • 49. BIOCORP
  • 50. Biomedical Devices of Kansas
  • 51. Biomedical Innovations (acquired by Graphic Controls)
  • 52. Biomerics
  • 53. Biotectix (acquired by Heraeus Medical Components)
  • 54. BIOTEQUE
  • 55. BIT
  • 56. Bob (acquired by ARCH Global Precision)
  • 57. BPL Medical Technologies
  • 58. BQ Plus Medical
  • 59. Bradshaw Medical (acquired by In'Tech Medical)
  • 60. BridgeMed Solutions
  • 61. Bridgemedica
  • 62. C&J Industries
  • 63. Cactus Semiconductor (acquired by Cirtec Medical)
  • 64. Cadence
  • 65. Canon Virginia
  • 66. Canwell Medical
  • 67. Caprock (acquired by NN)
  • 68. Caragh Precision
  • 69. Carclo
  • 70. CardioCommand
  • 71. Caribou Technologies (acquired by Resonetics)
  • 72. Carolina Precision Technologies
  • 73. CCB Medical Devices
  • 74. CCC Medical Devices (acquired by Greatbatch)
  • 75. Celestica
  • 76. Centex Machining
  • 77. Cerberus Capital Management
  • 78. Ceutical Labs
  • 79. Charlesbank Capital Partners
  • 80. Chester Medical Solutions
  • 81. Cirtec Medical
  • 82. Clada Medical Devices (acquired by Nordson)
  • 83. Coastal Life Technologies (acquired by Viant Medical)
  • 84. Coastline International
  • 85. Coghlin Companies
  • 86. Command Medical Products
  • 87. Concept Molds (acquired by Medbio)
  • 88. Confluent Medical Technologies
  • 89. Consort Medical
  • 90. Contech Medical
  • 91. Contract Medical International
  • 92. CoorsTek Medical
  • 93. Corpus Medical (acquired by Confluent Medical Technologies)
  • 94. Creagh Medical (acquired by SurModics)
  • 95. Creganna Medical (acquired by TE Connectivity)
  • 96. Cretex Medical
  • 97. CRI Medical Devices (acquired by BiomericsATL)
  • 98. Cytophil
  • 99. D&M Plastics
  • 100. Dartex Holdings (acquired by Trelleborg Sealing Solutions)
  • 101. Degania Medical (acquired by 3i Group)
  • 102. DeGood Dimensional Concepts
  • 103. DeviceLab
  • 104. Devicix (acquired by Nortech Systems)
  • 105. Diversified Plastics
  • 106. Doctor Pack
  • 107. Donatelle
  • 108. DRT Medical (acquired by NN)
  • 109. DSM
  • 110. DynaFlex Technologies
  • 111. East West Manufacturing
  • 112. Eastek International
  • 113. Ecomedis Medizintechnik
  • 114. EG-GILERO
  • 115. EGI Health
  • 116. Electronic Instrumentation and Technology
  • 117. Electronic Manufacturing Technology (acquired by Sparton)
  • 118. Elos Medtech
  • 119. Emerald Medical Services
  • 120. eNNOVEA
  • 121. ETE Medical (acquired by Confluent Medical Technologies)
  • 122. Eurazeo
  • 123. Eurocoating
  • 124. Europlaz Technologies
  • 125. EVCO Plastics
  • 126. Evergreen Medical Technologies (acquired by Heraeus Medical Components)
  • 127. Fabrico Medical
  • 128. Farm Design (acquired by Flex)
  • 129. Fermatex Vascular Technologies (acquired by Spectrum Plastics Group)
  • 130. Filtertek
  • 131. Finortho (acquired by Marle)
  • 132. Flex
  • 133. Flexan
  • 134. FMI Hansa Medical Products
  • 135. FMI Instrumed
  • 136. Forefront Medical Technology
  • 137. Formed Polymer Solutions (acquired by Venta Medical)
  • 138. Fortimedix
  • 139. Freudenberg Medical
  • 140. FTT Manufacturing
  • 141. FutureMatrix Interventional (acquired by Biomerics)
  • 142. General Microcircuits (acquired by East West Manufacturing)
  • 143. Genesis Plastics Welding
  • 144. Gerresheimer
  • 145. GILERO Biomedical
  • 146. GlaxoSmithKline
  • 147. GMI
  • 148. Golden Gate Capital
  • 149. Gooch & Housego
  • 150. Graham Partners
  • 151. Graphic Controls
  • 152. Greatbatch
  • 153. GTIMD Catheter Solutions
  • 154. GW Plastics
  • 155. H&T Presspart
  • 156. Hammarplast Medical
  • 157. Harmac Medical Products
  • 158. Haywood Vocational Opportunities
  • 159. HD Surgical (acquired by Tecomet)
  • 160. HDA Technology
  • 161. Health Line International
  • 162. Helix Medical
  • 163. Hemoteq (acquired by Freudenberg Medical)
  • 164. Heraeus Medical Components
  • 165. IEC Electronics
  • 166. IK Investment Partners
  • 167. In'Tech Medical
  • 168. InField Medical
  • 169. Infus Medical
  • 170. Injectronics (acquired by Phillips-Medisize)
  • 171. Innovolt (acquired by East West Manufacturing)
  • 172. Instru-Med
  • 173. INTAI Technology
  • 174. Integer
  • 175. Inteprod
  • 176. Interface Catheter Solutions (acquired by Nitinol Devices & Components)
  • 177. Interplex
  • 178. IntroMed (acquired by Flexan)
  • 179. Inzign
  • 180. Ironwood Industries
  • 181. I-Tek Medical Technologies
  • 182. ITL Group (acquired by Gooch & Housego)
  • 183. ITMC Medical
  • 184. Jabil
  • 185. Jade Precision Medical Components
  • 186. Janco Electronics
  • 187. JLL Partners
  • 188. Johari Digital Healthcare
  • 189. J-Pac Medical
  • 190. JunoPacific
  • 191. Katecho
  • 192. Kelpac Medical
  • 193. Keystone Solutions Group
  • 194. KeyTronicEMS
  • 195. Kiefer Manufacturing (acquired by Switchback Medical)
  • 196. Kohlberg
  • 197. LAB Medical Manufacturing
  • 198. Lake Region Medical (acquired by Greatbatch)
  • 199. LANIX MED GLOBAL
  • 200. Laserage Technology (acquired by AMETEK)
  • 201. Lathrop Engineering (acquired by Paramit)
  • 202. Lawrence Tool & Engineering (acquired by JunoPacific)
  • 203. Leghe Leggere Lavorate
  • 204. Life Science Outsourcing
  • 205. Lighthouse Imaging
  • 206. Linden Capital Partners
  • 207. LISI MEDICAL
  • 208. Litron (acquired by Pacific Aerospace & Electronics)
  • 209. LSMED
  • 210. Lubrizol
  • 211. Lucas Medical
  • 212. Lumenous Peiertech
  • 213. M K Precision (acquired by Carolina Precision Technologies)
  • 214. M&M Qualtech
  • 215. Mack Molding
  • 216. Marle
  • 217. Marman Industries
  • 218. Martech Medical Products
  • 219. McFarlane Medical
  • 220. Mectalent
  • 221. Medacys (now EG-MEDACYS)
  • 222. Medbio
  • 223. MEDEFAB
  • 224. Medelec (acquired by Resonetics)
  • 225. Medical Murray
  • 226. Medicom Innovation Partner (acquired by Phillips-Medisize)
  • 227. Mediliant
  • 228. MEDI-LINE (acquired by Nexeon MedSystems)
  • 229. Medis Medical
  • 230. MedPlast
  • 231. MedRes Medical Research Engineering
  • 232. MEDRON (acquired by Flexan)
  • 233. MeHow Medical
  • 234. Meridian Medical Technologies
  • 235. Metal Craft
  • 236. Metrigraphics (acquired by Cirtec Medical)
  • 237. Micro Medical Devices
  • 238. MicroGroup (acquired by TE Connectivity)
  • 239. Micron Laser Technology
  • 240. Micropulse
  • 241. Midwest Interventional Systems
  • 242. Millennium Surgical (acquired by Avalign Technologies)
  • 243. MME Group
  • 244. MMI Precision (acquired by Sil-Pro)
  • 245. Modern Medical
  • 246. Modulus
  • 247. Molex
  • 248. Montagu Private Equity
  • 249. Mound Laser & Photonics Center (acquired by Resonetics)
  • 250. Mountainside Medical (acquired by Tecomet)
  • 251. NACS
  • 252. Nanosurfaces Industries (acquired by CoorsTek Medical)
  • 253. Natech Plastics
  • 254. NATEL Engineering The manufacturing division was acquired by Eurocoating
  • 255. Nemera
  • 256. Neotech Medical
  • 257. NeraTek
  • 258. Nexcore Technology
  • 259. Nexeon MedSystems
  • 260. NextPhase Medical Devices
  • 261. Nissha
  • 262. Nitinol Devices & Components
  • 263. NN
  • 264. Nordic Capital
  • 265. Nordson
  • 266. Norman Noble
  • 267. NorMedix (acquired by SurModics)
  • 268. Nortech Systems
  • 269. Northeast Biomedical
  • 270. Norwood Medical
  • 271. Nova Biomedical
  • 272. Oberg Industries
  • 273. Occam Design
  • 274. Oerlikon AM
  • 275. OnCore Manufacturing Services
  • 276. Onyx Medical (acquired by Elos Medtech)
  • 277. Orchid Orthopedic Solutions
  • 278. Ortho Solutions (acquired by In'Tech Medical)
  • 279. OrthoGrind (acquired by ARCH Global Precision)
  • 280. Oscor
  • 281. Oval Medical Technologies (acquired by SMC)
  • 282. Oxygen 2 Innovation
  • 283. Oy Finnsusp
  • 284. P3 Medical
  • 285. Pacific Aerospace & Electronics
  • 286. Pacific Plastics Injection Molding (acquired by Diversified Plastics)
  • 287. Paragon Medical (acquired by NN)
  • 288. Paramit
  • 289. Penlon
  • 290. Peridot
  • 291. Pexco
  • 292. Pharma Tech
  • 293. Phase 2 Medical Manufacturing (acquired by Nexcore Technology)
  • 294. Phillips-Medisize (acquired by Molex)
  • 295. Phoenix DeVentures
  • 296. Placer Inspection Lab & Manufacturing
  • 297. Plastikon
  • 298. Plexus
  • 299. PMC SMART Solutions
  • 300. Point Medical
  • 301. Polymerex Medical
  • 302. Polyzen
  • 303. PPC Industries
  • 304. Precision Engineered Products (acquired by NN)
  • 305. Precision Extrusion (acquired by Pexco)
  • 306. Precision (acquired by TT Electronics)
  • 307. Precision MicroFab
  • 308. Precision Tool & Die (acquired by Carclo)
  • 309. Precision Wire Components (acquired by Creganna Medical)
  • 310. Preco
  • 311. Pro-Dex
  • 312. Product Resources
  • 313. Production Medical
  • 314. ProTek Medical (acquired by Molex)
  • 315. Proven Process Medical Devices
  • 316. Providence Enterprise
  • 317. Providien
  • 318. Pyng Medical (acquired by Teleflex)
  • 319. Pyxidis (acquired by In'Tech Medical)
  • 320. Q Holding
  • 321. Qmedics
  • 322. Quality Tech Services (acquired by Cretex Medical)
  • 323. Quasar
  • 324. RBC Medical Innovations
  • 325. Real-Time Enterprises (acquired by Sparton)
  • 326. ReCathCo
  • 327. Red Star Contract Manufacturing (acquired by WishBone Medical)
  • 328. Regatta Medical
  • 329. Rehab-Robotics
  • 330. Remington Medical
  • 331. Resonetics (acquired by Sverica International)
  • 332. Riverside Medical Packaging
  • 333. RK Manufacturing
  • 334. Robling Medical
  • 335. Röchling Medical
  • 336. Rose Medical
  • 337. RUA Medical
  • 338. SanaVita Medical
  • 339. Sanbor Medical
  • 340. Sanmina
  • 341. Saraca Solutions
  • 342. Schivo Precision
  • 343. Seabrook International (acquired by ARCH Global Precision)
  • 344. Second Source Medical
  • 345. Sequel Special Products (acquired by Graphic Controls)
  • 346. SFS
  • 347. Shanghai Yu Xing Medical Device (acquired by BQ Plus Medical)
  • 348. SHL Group
  • 349. Shree Pacetronix
  • 350. Silicone Altimex (acquired by Q Holding)
  • 351. Sil-Pro (acquired by Trelleborg Sealing Solutions)
  • 352. SIM Surgical
  • 353. Siora Surgicals
  • 354. Sky Medical
  • 355. SMB Medical (acquired by Marle)
  • 356. SMC
  • 357. Southmedic
  • 358. Sovrin Plastics
  • 359. Sparqtron
  • 360. Sparton
  • 361. SpecialTeam
  • 362. Specialty Silicone Fabricators (acquired by Trelleborg Sealing Solutions)
  • 363. Spectrum Plastics Group
  • 364. Starboard Medical
  • 365. StarFish Medical
  • 366. Stellar Technologies (acquired by Cirtec Medical)
  • 367. Stellartech Research
  • 368. Stericom (acquired by P3 Medical)
  • 369. SteriPack (acquired by Bemis)
  • 370. Sterling Industries
  • 371. Stevanato Group
  • 372. Stevenson Grantech
  • 373. STI Laser Industries (acquired by Resonetics)
  • 374. Strategix Medical Solutions
  • 375. Streamline Electronics Manufacturing
  • 376. Structure Medical
  • 377. Sumitomo Bakelite
  • 378. Sunshine Orthopaedics
  • 379. SURGIMEDIK
  • 380. SurModics
  • 381. Suzhou Jenitek
  • 382. Sverica International
  • 383. Swift Manufacturing & Engineering
  • 384. Switchback Medical
  • 385. Symmetry Medical
  • 386. Synecco
  • 387. Tangible Solutions
  • 388. Tapecon
  • 389. TE Connectivity
  • 390. Team Manufacturing (acquired by East West Manufacturing)
  • 391. TECHLAB
  • 392. Teco Diagnostics
  • 393. Tecomet
  • 394. Tecum Capital Partners
  • 395. Tegra Medical (acquired by SFS)
  • 396. Teleflex
  • 397. TEN.MedPrint
  • 398. TESco Associates
  • 399. Tessy Plastics
  • 400. The Jordan Company
  • 401. The Kangaroo Group
  • 402. Thortex (acquired by Avalign Technologies)
  • 403. Top Tool (acquired by Cirtec Medical)
  • 404. Trelleborg Sealing Solutions
  • 405. Trend Technologies
  • 406. TRICOR Systems
  • 407. Trident Manufacturing
  • 408. Truer Medical
  • 409. TT Electronics
  • 410. Tube Hollows International (acquired by Confluent Medical Technologies)
  • 411. Turner Medical (acquired by In'Tech Medical)
  • 412. Twin City EDM and Manufacturing
  • 413. Universal Precision Instruments (acquired by ARCH Global Precision)
  • 414. ValTech
  • 415. Valtronic
  • 416. VascoMed
  • 417. Vascotube (acquired by Cirtec Medical)
  • 418. VascuTech Medical
  • 419. Vaupell (acquired by Sumitomo Bakelite)
  • 420. Venta Medical (acquired by Laserage Technology)
  • 421. Vention Medical
  • 422. Veracity Medical (acquired by Arcamed)
  • 423. Vesta (acquired by Lubrizol)
  • 424. Via Biomedical
  • 425. Viant Medical
  • 426. Vincent Medical
  • 427. VitalDyne Medical
  • 428. VitalMED (acquired by Kelpac Medical)
  • 429. ViVO Smart Medical Devices
  • 430. Vosfox Medical
  • 431. W.L. Gore & Associates (acquired by Helix Medical)
  • 432. Water Street Healthcare Partners
  • 433. Wayglen (acquired by Advant Medical)
  • 434. West Pharmaceutical Services
  • 435. Westec Plastics
  • 436. Western Allegheny Capital Partners
  • 437. Westmed
  • 438. Wickstrom Rapid Tooling (acquired by JunoPacific)
  • 439. Winnomed
  • 440. WishBone Medical
  • 441. WuXi AppTec
  • 442. Xeridiem Medical Devices (acquired by PPC Industries)
  • 443. X-L Engineering (acquired by Oberg Industries)
  • 444. Ypsomed
  • 445. Zenius
  • 446. Zollner Elektronik
Back to Top